Compared with the shRNA control, TRIM59 knockdown decreased expression of p-STAT3, proliferation marker Ki-67, and cancer cell stemness marker CD44, whereas the levels of mH2A1 was elevated in GSC xenograft tumor tissues by immunohistochemical (IHC) analyses. The gene discussed is TRIM59; the disease is neoplasm.